genistein-17.1A immunoconjugate

to enhance the activity of genistein against colon cancer cells, it was coupled to monoclonal antibody 17.1A, which recognizes an epithelial membrane antigen that is overexpressed in colon cancer

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Constantinou, Andreas I: 1 article (05/2003)
2.	Das Gupta, Tapas K: 1 article (05/2003)
3.	Gentile, Michelle S: 1 article (05/2003)
4.	Green, Albert: 1 article (05/2003)
5.	Murillo, Genoveva: 1 article (05/2003)
6.	Prabhakar, Bellur S: 1 article (05/2003)
7.	Salti, George I: 1 article (05/2003)
8.	Vasu, Chenthamarakshan: 1 article (05/2003)

Related Diseases

1.	Colonic Neoplasms (Colon Cancer) 05/01/2003 - "Gen-17.1A significantly inhibited colon cancer cell growth in vitro and in vivo. " 05/01/2003 - "Targeting colon cancer cells with genistein-17.1A immunoconjugate." 05/01/2003 - "Gen-17.1A induced apoptosis in colon cancer cells as evidenced by the acridine orange/ethidium bromide staining method. "

Related Drugs and Biologics

1.	Ethidium (Ethidium Bromide)
2.	Acridine Orange